January 6, 2026 - 03:24

BENGALURU, KARNATAKA, INDIA, January 5, 2026 — Astrikos AI has announced a significant strategic investment from Gorilla Technology Group, a leader in AI-driven solutions encompassing Security Intelligence, Network Intelligence, Business Intelligence, and IoT technology. This partnership is poised to enhance Astrikos AI's capabilities and accelerate its global growth initiatives.
The investment will enable Astrikos AI to expand its reach in international markets while bolstering its development pipeline. By leveraging Gorilla's expertise and resources, Astrikos aims to innovate and enhance its offerings, positioning itself as a formidable player in the AI landscape.
Astrikos AI's leadership expressed optimism about the collaboration, highlighting that this investment not only provides financial backing but also strategic insights that will drive the company's vision forward. As the demand for AI solutions continues to rise globally, this partnership is expected to play a crucial role in meeting the evolving needs of businesses across various sectors.
August 9, 2026 - 18:31
County agenda features tax, technology and fairgroundsThe meeting will center on how to fund the ongoing fairgrounds project, a long-discussed priority for the county. Officials are expected to review the latest cost estimates and possible revenue...
August 9, 2026 - 00:24
‘AI slop’ crackdown: LinkedIn, Snap target low-quality gen-AI contentSocial platforms are starting to push back against the flood of generic, machine-generated posts, but they are doing so carefully. LinkedIn and Snap have both announced new measures aimed at...
August 8, 2026 - 05:47
Why GigaCloud Technology (GCT) Is Up 21.7% After Strong Q2 Results And New Buyback PlanGigaCloud Technology saw its stock surge 21.7% in early trading following the release of its second-quarter financial results and the announcement of a new capital return program. The company...
August 7, 2026 - 22:40
As FDA Approves First-Ever mRNA Flu Vaccine For Older Adults, Past KFF Polling Showed Most In This Age Group Were Uncertain About the Technology’s SafetyOn August 5, 2026, the U.S. Food and Drug Administration gave the green light to the first messenger RNA flu vaccine for adults aged 50 and older. The decision came after a clinical trial involving...